Literature DB >> 1969334

Autonomic function in hypertension. Are there racial differences?

R J Parmer1, J H Cervenka, R A Stone, D T O'Connor.   

Abstract

Previous biochemical assessment of sympathetic nervous system activity including plasma catecholamines, plasma renin activity, and plasma dopamine-beta-hydroxylase levels has suggested racial differences in the contribution of the sympathetic nervous system to the pathogenesis or maintenance of hypertension. We, therefore, performed physiological and pharmacological studies in white and black subjects with essential hypertension and their age-matched normotensive counterparts to assess autonomic and sympathetic nervous system function. One hundred one male subjects (47 white hypertensive, 17 black hypertensive, 22 white normotensive, and 15 black normotensive subjects) were evaluated for baroreceptor reflex sensitivity to low-pressure (amyl nitrite inhalation) and high-pressure (phenylephrine infusion) stimuli; cold pressor test heart rate and blood pressure responses; and blood pressure response to phentolamine alpha-adrenergic blockade. Hypertensive subjects exhibited an increase in resting heart rate, a decrease in baroreceptor reflex sensitivity, and an exaggerated decline in mean arterial pressure in response to phentolamine. These abnormalities were present to a comparable degree in black and white hypertensive subjects. Cold pressor testing revealed greater increases in heart rate in blacks as compared with whites; however, this racial difference was present regardless of blood pressure status, occurring in black normotensive and black hypertensive subjects to a comparable degree. Cold pressor test blood pressure increments were similar in the four groups. We conclude that both white hypertensive and black hypertensive subjects demonstrate similar abnormalities in autonomic and sympathetic nervous system function including blunting of baroreceptor reflex sensitivity and an increased alpha-adrenergic receptor participation in blood pressure maintenance. The results do not suggest major racial differences in autonomic pathogenetic mechanisms in hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969334     DOI: 10.1161/01.cir.81.4.1305

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.

Authors:  Yuqing Chen; Michael S Lipkowitz; Rany M Salem; Maple M Fung; Vibha Bhatnagar; Manjula Mahata; Caroline M Nievergelt; Fangwen Rao; Sushil K Mahata; Nicholas J Schork; Pamela J Hicks; Donald W Bowden; Barry I Freedman; Victoria H Brophy; Daniel T O'Connor
Journal:  Am J Nephrol       Date:  2010-05-19       Impact factor: 3.754

Review 3.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

4.  Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.

Authors:  Wen Shang; Ping Han; Cheng-bing Yang; Xiao-wen Gu; Wei Zhang; Li-ping Xu; Shou-ting Fu; Ding-feng Su; He-hui Xie
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

5.  The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles.

Authors:  Qijiao Jiang; Neill A Gingles; Marc A Olivier; Lindsey A Miles; Robert J Parmer
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

6.  Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses.

Authors:  Daniel Kurnik; Eitan A Friedman; Mordechai Muszkat; Gbenga G Sofowora; Hong-Guang Xie; William D Dupont; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

7.  Social context as an explanation for race disparities in hypertension: findings from the Exploring Health Disparities in Integrated Communities (EHDIC) Study.

Authors:  Roland J Thorpe; Dwayne T Brandon; Thomas A LaVeist
Journal:  Soc Sci Med       Date:  2008-08-12       Impact factor: 4.634

8.  Chromogranin A polymorphisms are associated with hypertensive renal disease.

Authors:  Rany M Salem; Peter E Cadman; Yuqing Chen; Fangwen Rao; Gen Wen; Bruce A Hamilton; Brinda K Rana; Douglas W Smith; Mats Stridsberg; Harry J Ward; Manjula Mahata; Sushi K Mahata; Donald W Bowden; Pamela J Hicks; Barry I Freedman; Nicholas J Schork; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

9.  Adrenergic polymorphism and the human stress response.

Authors:  Fangwen Rao; Lian Zhang; Jennifer Wessel; Kuixing Zhang; Gen Wen; Brian P Kennedy; Brinda K Rana; Madhusudan Das; Juan L Rodriguez-Flores; Douglas W Smith; Peter E Cadman; Rany M Salem; Sushil K Mahata; Nicholas J Schork; Laurent Taupenot; Michael G Ziegler; Daniel T O'Connor
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Sweat output measurement of the post-ganglion sudomotor response by Q-Sweat test: a normative database of Chinese individuals.

Authors:  Shu-Fang Chen; Ya-Ting Chang; Cheng-Hsien Lu; Chi-Ren Huang; Nei-Wen Tsai; Chiung-Chih Chang; Chih-Cheng Huang; Yao-Chung Chuang; Wen-Neng Chang
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.